Cellular senescence was assessed by SA--galactosidase staining (SA--gal staining) using senescence -galactosidase Staining Kit (Cell Signaling Technology, Beverly, MA, United States) according to the manufacturers instructions
How Topical GHK-Cu Works Topical copper peptides act locally on the skin to: Stimulate fibroblasts Increase collagen and elastin production Improve skin thickness and texture Support the skin barrier Benefits of Topical Copper Peptides Non-invasive and easy to use Lower systemic exposure (especially in individuals with elevated or high-normal copper levels) Ideal for long-term skin maintenance Helpful for fine lines, wrinkles, tone, and texture Well-suited for prevention and early intervention Limitations Localized effects only Results are gradual and require consistent use Best For Patients focused on skin longevity and appearance Preventative or maintenance care Those who prefer non-injectable options Injectable Copper Peptides (GHK-Cu) Injectable GHK-Cu delivers copper peptides systemically , meaning effects extend beyond the skin
Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population
8 CAP Code Section 12 also requires medicines to be properly licensed before they are marketed and restricts medicinal claims for unlicensed products
